Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
Authors: Grasselli, J.1,2, Elez, E.1,3, Caratù, G.4, Matito, J.4, Santos, C.2, Macarulla, T.1,3, Vidal, J.5, Garcia, M.2, Viéitez, J. M.6, Paéz, D.7, Falcó, E.8, Lopez Lopez, C.9, Aranda, E.10, Jones, F.11, Sikri, V.11, Nuciforo, P.12, Fasani, R.12, Tabernero, J.1,3, Montagut, C.5, Azuara, D.13
Source: Annals of Oncology. Jun2017, Vol. 28 Issue 6, p1294-1301. 8p. 2 Charts, 3 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdx112